Overview of Dr. Laber
Dr. Damian Laber is a hematologist and medical oncologist in Tampa, FL, Senior Member at the H. Lee Moffitt Cancer Center and Research Institute, Professor of Medicine, Professor of Oncologic Sciences and Director of the Division of Hematology/Oncology at the University of South Florida. He received his medical degree from University of Buenos Aires, and trained at the Cleveland Clinic, Fred Hutchinson Cancer Center, Baylor College of Medicine and MD Anderson Cancer Center. He has been in practice for over 25 years. He specializes in gastrointestinal cancer, genitourinary oncology, and hematology and is experienced in neuro-oncology, hematologic oncology, breast cancer, bleeding and clotting disorders. He has more than 60 publications and over 500 citings.
Office
4101 Jim Walter Blvd
Tampa, FL 33607Fax+1 813-449-8225
Education & Training
- Baylor College of MedicineFellowship, Hematology and Medical Oncology, 1997 - 2000
- Huron HospitalResidency, Internal Medicine, 1994 - 1997
- University of Buenos AiresClass of 1992
Certifications & Licensure
- FL State Medical License 2013 - 2025
- IN State Medical License 1999 - 2021
- OK State Medical License 2011 - 2014
- KY State Medical License 2001 - 2011
- TX State Medical License 2000 - 2008
- WA State Medical License 1995 - 1996
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies Start of enrollment: 2005 Apr 01
Publications & Presentations
PubMed
- 4 citationsCase Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with OxaliplatinDaniel Kerr, Damian A. Laber, Nathan Visweshwar, Michael Jaglal
Anticancer Research. 2018-03-01 - 259 citationsA phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma.Jonathan E. Rosenberg, Richard Martin Bambury, Eliezer M. Van Allen, Harry A. Drabkin, Primo N. Lara
Investigational New Drugs. 2014-02-01 - 568 citationsDiscovery and Development of the G-rich Oligonucleotide AS1411 as a Novel Treatment for CancerPaula J. Bates, Damian A. Laber, Donald M. Miller, Shelia D. Thomas, John O. Trent
Experimental and Molecular Pathology. 2009-06-01
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Oklahoma BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPOFirst Health PPO
Great West PPO
Harvard Pilgrim HMO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: